MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$69,487,620
Deemed dividend
related to warrant...
$54,326,896
Net loss
attributable to bnb plus corp
-$15,160,724
Less net loss
attributable to...
-$188,522
Net loss
-$15,349,246
Dna Tagging And
Security Products
$553,476
Therapeutic Dna Production
$159,312
Dna Tagging And
Security Products
$595,341
Therapeutic Dna Production
$828,806
Net loss from
discontinued operations, net...
-$392,731
Net loss from
continuing operations
-$14,956,515
Income tax provision
benefit
-$684,115
Service
$712,788
Product
$1,424,147
Net loss from
discontinued operations
-$392,731
Loss before
provision for income taxes
-$15,640,630
Other expense, net
$36,600
Interest (income)
$3,301
Unrealized gain on change in
fair value of...
-$319,630
Interest income
$192,915
Total revenues
$2,136,935
Selling, general and
administrative
$215,105
Gross profit
-$217,527
Other expense, net
-$106,580
Loss from operations
-$16,046,595
Clinical laboratory
service revenues
$572,928
Gross profit
$838,907
Cost of product
revenues
$1,298,028
Cost of clinical
laboratory service...
$790,455
Total operating
expenses
$16,885,502
Research and development
$6,016,912
Selling, general and
administrative
$10,868,590
Back
Back
Income Statement
source: myfinsight.com
bnbx: the income statement
BNB PLUS CORP. (BNBX)
BNB PLUS CORP. (BNBX)